Spectrum Pharmaceuticals, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Spectrum Pharmaceuticals, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Spectrum Pharmaceuticals, Inc. stocks after a simple registration process. </div>

Q: How to buy Spectrum Pharmaceuticals, Inc. shares in India?

<div> To buy Spectrum Pharmaceuticals, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Spectrum Pharmaceuticals, Inc. and you are done!</div> </div>

Q: What is the share price of Spectrum Pharmaceuticals, Inc.?

<div>The share price of Spectrum Pharmaceuticals, Inc. is USD 0.88 as on 3 Aug.</div>

Q: What is the Market Capitalization of Spectrum Pharmaceuticals, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Spectrum Pharmaceuticals, Inc. is USD 158.48M as on 3 Aug.</div>

Q: What is the PE ratio of Spectrum Pharmaceuticals, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Spectrum Pharmaceuticals, Inc. is N/A as on 3 Aug. </div>

Q: Is Spectrum Pharmaceuticals, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Spectrum Pharmaceuticals, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Spectrum Pharmaceuticals, Inc. operate?

<div> Spectrum Pharmaceuticals, Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$0.88

+0.04

(3 Aug)

Loading Chart

Previous close

$0.88

Open

$0.88

52W high

$3.26

5.38%

-58.06%

Shares O/S

180.09M

Market cap

158.48M

Insights

No insights found for this stock

Compare with other stock

About Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. Its pipeline products include ROLONTIS, Poziotinib and Anti-CD20-IFNa. ROLONTIS (eflapegrastim injection), is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia.

Poziotinib, is a pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. Anti-CD20-IFNa, is an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for treating relapsed or refractory non-Hodgkin's lymphoma (NHL) patients. .

FAQs

Can I buy Spectrum Pharmaceuticals, Inc. shares in India?

How to buy Spectrum Pharmaceuticals, Inc. shares in India?

What is the share price of Spectrum Pharmaceuticals, Inc.?

What is the Market Capitalization of Spectrum Pharmaceuticals, Inc.?

What is the PE ratio of Spectrum Pharmaceuticals, Inc.?

Is Spectrum Pharmaceuticals, Inc. a good stock to buy?

In which sector / industry does Spectrum Pharmaceuticals, Inc. operate?